| Rank |
Status |
Study |
| 1 |
Not yet recruiting
|
Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-MYALGIA
| Conditions: |
Taxane; Drug-related Side Effects and Adverse Reactions; Pain; Breast Cancer |
| Interventions: |
Drug: Pregabalin; Drug: Placebo |
| Outcome Measures: |
Integrated Numeric Pain Scores and Rescue Analgesic Medication Requirement as calculated by the method proposed by Silverman et al (Silverman, O'Connor et al. 1993).; Numeric Pain Score (NPS); The additional number of hours spent in horizontal position (∆HHP**); FACT-taxane score |
|
| 2 |
Recruiting
|
IV Ibuprofen for Post-Electroconvulsive Therapy MYALGIA
| Condition: |
Depression |
| Interventions: |
Drug: Placebo infusion; Drug: ibuprofen intravenous |
| Outcome Measures: |
Pre-treatment with intravenous ibuprofen will attenuate the incidence & severity of post ECT MYALGIAs; Pre-treatment with IV ibuprofen will attenuate and decrease the severity of post ECT headache |
|
| 3 |
Recruiting
|
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
| Condition: |
Delayed Onset Muscle Soreness |
| Intervention: |
Drug: Acetaminophen 1000mg |
| Outcome Measures: |
SPID (Sum Pain Intensity Difference); spontaneous muscle pain/soreness; Muscle stiffness with movement; Overall evaluation measures |
|
| 4 |
Recruiting
|
Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
| Conditions: |
Osteoarthritis; Rheumatoid Arthritis; Lower Back Pain; Joint Pain; Muscle Pain |
| Intervention: |
Drug: Buprenorphine transdermal patch |
| Outcome Measures: |
Efficacy according to BS-11 pain score; Secondary efficacy outcome; Adverse events |
|
| 5 |
Recruiting
|
Effects of a Polyherbal Supplement on the Signs and Symptoms of Delayed Onset Muscle Soreness
| Condition: |
Delayed Onset Muscle Soreness |
| Interventions: |
Dietary Supplement: Polyherbal capsule; Dietary Supplement: Placebo capsule |
| Outcome Measures: |
Change from baseline in peak muscle strength on Day 2 of each test period after eccentric exercise.; Change from baseline in peak muscle strength after eccentric exercise; Change from baseline in pain assessment after eccentric exercise; Change from baseline in flexibility after eccentric exercise; Change from baseline in elbow girth (swelling) after eccentric exercise; Change from baseline in muscle tenderness after eccentric exercise; Change from baseline in creatinine kinase (CK) and C-reactive protein (CRP) levels after eccentric exercise |
|
| 6 |
Available
|
Effect of American Ginseng on Exercise-induced Muscle Soreness
| Condition: |
Exercise-induced Muscle Soreness |
| Intervention: |
Dietary Supplement: Ginseng |
| Outcome Measure: |
|
|
| 7 |
Recruiting
|
Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension MYALGIA
| Condition: |
Pelvic Floor Muscle Spasm |
| Interventions: |
Drug: Pudendal block; Drug: Placebo |
| Outcome Measures: |
Visual analog pain score after 6 weekly injections; Improvement in pelvic floor symptoms as assessed through standardized questionnaires |
|
| 8 |
Recruiting
|
An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Analgesic Efficacy and Safety of Voltaren Gel (1% Diclofenac Sodium) Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
| Condition: |
Delayed Onset Muscle Soreness |
| Interventions: |
Drug: 1% diclofenac sodium gel; Drug: Placebo |
| Outcome Measure: |
To assess analgesic efficacy of Topical Voltaren® gel compared to placebo |
|
| 9 |
Unknown †
|
Efficacy and Safety of Salonsip Compared to Sabiá Plaster
| Conditions: |
Contusions; Sprains; MYALGIA; Pain; Tendonitis |
| Interventions: |
Drug: Salonsip plaster; Drug: Sabia plaster |
| Outcome Measures: |
Likert Scales and Visual Analogue Scales; Safety evaluation by adverse events relate. |
|
| 10 |
Unknown †
|
Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
| Conditions: |
Muscular Atrophy; Sprains; Tendonitis |
| Interventions: |
Drug: Ibuprofen; Drug: Profenid |
| Outcome Measures: |
Clinical study evaluating the efficacy and safety of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. "; Clinical study evaluating the tolerability of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. " |
|
| 11 |
Recruiting
|
Low Intensity Ultrasound Therapy for Upper Back Pain Relief
| Condition: |
Muscle Spasm |
| Interventions: |
Device: Sam Ultrasonic Diathermy Device (Active Device); Device: Sam Ultrasonic Diathermy Device (Placebo Device) |
| Outcome Measures: |
Change in pain on the visual analog scale (VAS); Comparison of pain level using Global Rating of Change (GROC) scale.; Change in trigger point depth |
|
| 12 |
Recruiting
|
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
| Conditions: |
Chronic Fatigue Syndrome; Myalgic Encephalomyelitis |
| Intervention: |
Drug: Etanercept |
| Outcome Measures: |
Symptom alleviation within 12 months follow-up, as compared to baseline, measured by standardized self-reports and quality of life schemes.; Symptom alleviation, as compared to baseline, measured by standardized self-reports and quality of life schemes. |
|
| 13 |
Not yet recruiting
|
Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy
| Conditions: |
Intubating Conditions; Postoperative MYALGIA; Patient Satisfaction |
| Interventions: |
Drug: Succinylcholine; Drug: Rocuronium 0,3; Drug: Rocuronium 0,6 |
| Outcome Measures: |
Intubating Condition; Postoperative MYALGIA |
|
| 14 |
Recruiting
|
Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
| Conditions: |
Intubating Conditions; Performance With Respiratory Exercise Device; Postoperative MYALGIA |
| Interventions: |
Drug: Succinylcholine; Drug: Mivacurium |
| Outcome Measures: |
Intubating condition; Postoperative MYALGIA; postintervention performance with a expiration exercise device |
|
| 15 |
Unknown †
|
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
| Condition: |
Postpoliomyelitis Syndrome |
| Interventions: |
Drug: L-carnitine and piracetam; Drug: Placebo |
| Outcome Measures: |
Changes in Muscle Weakness; Changes in fatigue; Changes in muscle pain; Changes in daytime sleepiness; Changes in quality of life; Changes in daily function; Changes in depressive mood; Changes in oxidative capacity in skeletal muscle; Occurrence of adverse events |
|
| 16 |
Unknown †
|
Hood to Coast Injury Study
| Condition: |
Pain |
| Interventions: |
Dietary Supplement: Tart Cherry Juice; Dietary Supplement: Fruit juice |
| Outcome Measure: |
The administration of tart cherry juice will reduce the symptoms of exercise-induced muscle damage as measured by patients assessment of pain on a standard VAS. |
|
| 17 |
Recruiting
|
Antibiotic Treatment of Multiple Erythema Migrans
| Condition: |
Multiple Erythema Migrans |
| Interventions: |
Drug: ceftriaxone; Drug: doxycycline; Other: erythema migrans patients treated with doxycycline |
| Outcome Measures: |
Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, MYALGIAs, paresthesias, dizziness, or irritability in patients treated for multiple erythema migrans with ceftriaxone or doxycycline for 15 days.; Comparison of subjective symptoms such as fatigue, malaise, arthralgias, headache, MYALGIAs, paresthesias, or irritability between patients treated with antibiotic for multiple erythema migrans and control subjects without a history of Lyme borreliosis.; Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, MYALGIAs, paresthesias, dizziness, or irritability in patients with solitary versus multiple erythema migrans after antibiotic treatment. |
|
| 18 |
Unknown †
|
Clinical Evaluation of QFlu Combo Test
| Conditions: |
Cough; MYALGIA; Nasal Obstruction; Sore Throat; Headache; Fatigue; Fever |
| Intervention: |
|
| Outcome Measures: |
Sensitivity and specificity for drug resistance detection; Sensitivity and Specificity of the Test for Influenza Diagnosis |
|
| 19 |
Unknown †
|
Effect of Propranolol on the Autonomic Nervous System and Muscle Pain
| Conditions: |
Temporomandibular Joint Disorders; Myofascial Temporomandibular Disorders |
| Interventions: |
Drug: Propranololhydrochlorid; Drug: Placebo |
| Outcome Measures: |
Pain intensity; Haemodynamic parameters |
|
| 20 |
Unknown †
|
Vitamin D Replacement in Statin-Induced Myopathy
| Condition: |
HMG COA Reductase Inhibitor Adverse Reaction |
| Interventions: |
Drug: Vitamin D (Cholecalciferol ); Drug: Placebo |
| Outcome Measures: |
lack of need to stop statin medication due to MYALGIA; reduction of visual analog pain score |
|
